PDCD1 and neoplasm: The NR-FMT mice displayed enhanced tumor growth rates and diminished responsiveness to anti-PD-1 therapy compared to their R-FMT counterparts, thereby reinforcing the notion that microbiota has a crucial regulatory function in ICI therapy.